Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

JMJD1C demethylase as novel target for AR-negative prostate cancer

Sep. 13, 2021

Jiangsu Simcere Pharmaceutical R&D patents DNA repair protein RAD51 homolog 1 inhibitors

Sep. 13, 2021

At WCLC, early steps towards success against SCLC

Sep. 10, 2021

Platinum(II)-NHC complex targeting vimentin inhibits tumor metastasis

Sep. 10, 2021

Flamingo and Ionis expand alliance to develop RNA-targeted therapies for oncology

Sep. 10, 2021

STM-2457: a first-in-class METTL3 inhibitor with preclinical proof of concept in AML models

Sep. 10, 2021

PearlRiverBio patents mutant EGFR/HER2 inhibitors

Sep. 10, 2021

HA-344 shows promise for treating cutaneous metastatic melanoma

Sep. 10, 2021

Salk Institute, Sanford Burnham Prebys describe new ULK1 inhibitors

Sep. 10, 2021

StemSynergy Therapeutics patents N-myc proto-oncogene protein inhibitors

Sep. 10, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...